STUTTGART, GERMANY — (Marketwired) — 10/01/14 — Overtech Corp. (OTCQB: OVET) Overtech Corp. (the “Company” or “Overtech”) is pleased to provide an update regarding its acquisition of Beatmungspflege 24 GmbH (The “GmbH”) announced on September 3, 2014.
The Company has been informed by the GmbH that the audit and review of its financial statements is continuing as planned and expects to be completed in early October. “A company such as Beatmungspflege with revenues and earnings is a large task to audit and we are pleased with the progress that the GmbH is making in the completion of this process,” commented Dr. Elmedina Adzemovic, President of Overtech.
The Company is also pleased to announce it has taken certain steps to list its shares for trade across various Stock Exchanges in Germany. The process is ongoing and is subject to approval. Updates will be provided as they are available.
Beatmungspflege 24 GmbH is primarily the offering of medical in-home care services including ventilation for patients that suffer from debilitating diseases such as Amyotrophic Lateral Sclerosis (ALS), Muscular Dystrophy (MD), Guillain-Barre syndrome (GBS), and Chronic Obstructive Pulmonary Disease (COPD). Other services include Acute post-patient care, Respiration optimization and monitoring of long-term home respiration with nationwide care available within 24 hours for all respiration cases.
The GmbH currently operates in the Stuttgart area with 7 local checkpoints with plans to open additional checkpoints throughout all major Germany cities. The checkpoints are locations where nurses pick up medication, supplies and equipment prior to visiting the patients in their homes.
Ambulatory care services and nursing care is a 27 billion EUR annual market in Germany
Forward-Looking Statements
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management–s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Overtech cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Overtech–s control. Such factors include, among other things: risks and uncertainties relating to Overtech–s business plan, Overtech–s ability to raise sufficient financing and Overtech–s limited operating history. There is no assurance that the required audited financial statements will be delivered or that the Share Purchase Agreement will close. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, Overtech undertakes no obligation to publicly update or revise forward-looking information. No stock exchange, securities commission or other regulatory body has reviewed nor accepts responsibility for the adequacy or accuracy of this release. Investors are advised to carefully review the reports and documents that Overtech Corp. files from time to time with the SEC, including its Annual, Quarterly and Current Reports.
Contacts:
Overtech Corp.
Dr. Elmedina Adzemovic
+49 162-779-1628
You must be logged in to post a comment Login